Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Arthritis, Rheumatoid 7Melanoma 4Colitis 3Carcinoma, Non-Small-Cell Lung 3Urogenital Neoplasms 2Lung Neoplasms 2Inflammatory Bowel Diseases 2Inflammation 2Fatigue 2Depressive Disorder, Major 2Depression 2Colitis, Ulcerative 2Vasculitis 1Takayasu Arteritis 1Syndrome 1Stroke 1Stevens-Johnson Syndrome 1Spondylitis, Ankylosing 1Skin Neoplasms 1Psoriasis 1Precancerous Conditions 1Pemphigoid, Benign Mucous Membrane 1Infections 1Hypertension 1Hepatitis C 1Hematologic Neoplasms 1Graft vs Host Disease 1Drug-Related Side Effects and Adverse Reactions 1Depressive Disorder, Treatment-Resistant 1Cytokine Release Syndrome 1

Interventions

Megestrol Acetate 9Mirtazapine 5Olanzapine 4anamorelin 2nabiximols 1nabilone 1Watchful Waiting 1Thalidomide 1Surveys and Questionnaires 1Sugars 1Radiotherapy 1Quality of Life 1Palonosetron 1Observation 1Nicotine 1Modafinil 1Minocycline 1Melatonin 1Megestrol 1Magnetic Resonance Spectroscopy 1Infliximab 1Flurandrenolone 1Etanercept 1Eicosapentaenoic Acid 1Dronabinol 1Docetaxel 1Dexamethasone 1Creatine 1Calcium Dobesilate 1Aromatherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Anorexia × Infliximab × Clear all
NCT00040885 2016-12-07

Docetaxel With or Without Infliximab in Treating Weight Loss, Loss of Appetite, and Fatigue in Patients With Unresectable Non-Small Cell Lung Cancer (Infliximab Treatment Discontinued Effective 10/05/05)

Alliance for Clinical Trials in Oncology

Phase 3 Completed
67 enrolled
Thoracic

Anorexia, Cachexia, Carcinoma, Non-Small-Cell Lung, Fatigue, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡